Charity Williams

Partner
Full contact info

Experience

Advanced Instruments Acquires and Merges With Nova Biomedical

March 19, 2025

Cooley advised Advanced Instruments, a subsidiary of Patricia Industries and a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, on intellectual property and licensing aspects in connection with its definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology therapeutics.

Read more

Related contacts

Joanna Liebes Hubberts
Partner, San Diego
Charity Williams
Partner, San Diego
Mika Reiner Mayer
Partner, Palo Alto
Lisa Amii
Patent Agent, Palo Alto
Michael Fernando
Associate, London
Gayana Stokes
Senior Paralegal, Washington, DC
John Paul Oleksiuk
Partner, New York
Colleen R. Wellington-Caban
Associate, Washington, DC
Leanne Andrepont
Senior Trademark Paralegal
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

EsoBiotec Announces up to $1 Billion Acquisition by AstraZeneca

March 17, 2025

Cooley advised EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity, on its definitive agreement to be acquired by AstraZeneca (London Stock Exchange/Nasdaq Stockholm/Nasdaq: AZN) for up to $1 billion on a cash- and debt-free basis.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Rowook Park
Partner, San Diego
Charity Williams
Partner, San Diego
Simon Amies
Partner, London
Russell Anderson
Partner, London
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Charlie Lightfoot
Partner, London
Alessandra Murata
Partner, Palo Alto
Dr. Matthew Pavao
Partner, Boston
Guadalupe Sampedro
Partner, London
Stella Sarma
Partner, Brussels
Leo Spicer-Phelps
Partner, London
Nicola Squire
Partner, London
Chris Stack
Partner, London
Jeffrey J. Tolin
Partner, New York
David Wilson
Partner, London
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jack Jones
Special Counsel, London
Dillon Martinson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Julie Wicklund
Special Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Kafeel Azher
Associate, London
Sarah Buchik
Associate, New York
Dr. Jessica Cande
Associate, Boston
Mari Dugas
Associate, Washington, DC
Michael Fernando
Associate, London
Athina Gaki
Associate, Brussels
Elaine Huang
Associate, Palo Alto
Mark Jones
Associate, London
Eerik Kukebal
Associate, London
Chris Lynn
Associate, London
Morgan McCormack
Associate, London
Daniel Millard
Associate, London
Lindsey O'Crump
Associate, Washington, DC
Alexandra Paterson
Associate, London
Dr. Robert E. Powers
Associate, Boston
Zhijing Yu
Associate, Singapore
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

Takara Bio Announces Acquisition of Curio Bioscience

January 15, 2025

Cooley advised Takara Bio, a global biotechnology and life sciences company headquartered in Shiga, Japan, on its acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics.

Read more

Related contacts

Laura M. Medina
Partner, Colorado
Charity Williams
Partner, San Diego
Dr. Bill Christiansen
Partner, Seattle
Meredith Klionsky
Special Counsel, Washington, DC
John Forrest
Associate, Boston
Jeff Gutkin
Partner, San Francisco
Jonathan Rivinus
Partner, Colorado
David Walsh
Senior Counsel, Reston
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Bryan Berman
Special Counsel, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Stefan Cohen
Associate, New York
Eileen Leman
Associate, Los Angeles
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Avenzo Therapeutics Announces Exclusive Global License Agreement With DualityBio

January 13, 2025

Cooley advised Avenzo Therapeutics, a clinical-stage biotechnology company developing next-generation oncology therapies, on its exclusive license agreement with Duality Biotherapeutics (DualityBio), pursuant to which Avenzo will develop, manufacture and commercialize AVZO-1418/DB-1418– a potential best-in-class epidermal growth factor receptor (EGFR)/human epidermal growth factor receptor 3 (HER3) bispecific antibody-drug conjugate (ADC) – globally (excluding Greater China). 

Read more

Related contacts

Charity Williams
Partner, San Diego
Dr. Chen Chen
Partner, Boston
Jonathan Kaufman
Associate, Palo Alto
Mika Reiner Mayer
Partner, Palo Alto
Dr. Mark Westwood
Associate, Palo Alto
Kimberly Bolin
Patent Agent, Palo Alto
Nitasha Bennett
Patent Agent, San Diego
Dr. Connie Tong
Patent Agent, Palo Alto
Amanda Pacheco
Associate, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York

Related Practices & Industries

Kura Oncology Announces Global Strategic Collaboration With Kyowa Kirin

November 20, 2024

Cooley advised clinical-stage biopharmaceutical company Kura Oncology (Nasdaq: KURA) on its global strategic collaboration with Kyowa Kirin to develop and commercialize ziftomenib, Kura’s selective oral menin inhibitor that is being investigated for the treatment of acute myeloid leukemia and other hematologic malignancies.

Read more

Related contacts

Charity Williams
Partner, San Diego
Dr. Chen Chen
Partner, Boston
Jonathan Kaufman
Associate, Palo Alto
Aaron Pomeroy
Partner, Colorado
Todd Gluth
Partner, San Diego
Amanda Pacheco
Associate, Palo Alto
Howard Morse
Senior Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Charles Bair
Partner, San Diego
Andrew Epstein
Special Counsel, Seattle
Rachel Thorn
Of counsel, New York
Wade Andrews
Special Counsel, San Diego
María Álvarez Requejo Heredero
Associate, Brussels
Zhijing Yu
Associate, Singapore
Natasha Leskovsek
Of Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

View more

Admissions and credentials

California

Rankings and accolades

Carnegie Mellon McGinnis Venture Competition, Life Sciences Grand Prize

Recipient, In-Awe Award from the Medical Marketing Association

San Diego Business Journal: Women of Influence in Law (2024)